M&T Bank’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-11,415
Closed -$2.1M 1582
2021
Q2
$2.1M Sell
11,415
-972
-8% -$179K 0.01% 550
2021
Q1
$1.89M Sell
12,387
-1,404
-10% -$215K 0.01% 575
2020
Q4
$2.15M Sell
13,791
-322
-2% -$50.3K 0.01% 556
2020
Q3
$1.62M Sell
14,113
-105
-0.7% -$12K 0.01% 579
2020
Q2
$1.6M Buy
+14,218
New +$1.6M 0.01% 571
2020
Q1
Sell
-15,412
Closed -$1.67M 1645
2019
Q4
$1.67M Sell
15,412
-733
-5% -$79.2K 0.01% 489
2019
Q3
$1.58M Sell
16,145
-356
-2% -$34.8K 0.01% 582
2019
Q2
$2.16M Sell
16,501
-270
-2% -$35.4K 0.01% 502
2019
Q1
$2.27M Sell
16,771
-3,021
-15% -$409K 0.01% 493
2018
Q4
$1.93M Buy
19,792
+489
+3% +$47.6K 0.01% 505
2018
Q3
$2.68M Sell
19,303
-12,669
-40% -$1.76M 0.01% 471
2018
Q2
$3.97M Buy
31,972
+819
+3% +$102K 0.02% 386
2018
Q1
$3.47M Sell
31,153
-1,743
-5% -$194K 0.02% 408
2017
Q4
$3.94M Sell
32,896
-4,796
-13% -$574K 0.02% 386
2017
Q3
$5.29M Buy
37,692
+5,407
+17% +$758K 0.03% 335
2017
Q2
$3.93M Buy
32,285
+9,080
+39% +$1.1M 0.02% 374
2017
Q1
$2.81M Sell
23,205
-3,955
-15% -$479K 0.02% 450
2016
Q4
$3.32M Sell
27,160
-747
-3% -$91.4K 0.02% 408
2016
Q3
$3.42M Sell
27,907
-1,084
-4% -$133K 0.02% 396
2016
Q2
$3.38M Sell
28,991
-2,154
-7% -$251K 0.02% 399
2016
Q1
$4.34M Sell
31,145
-1,024
-3% -$143K 0.03% 355
2015
Q4
$6.14M Sell
32,169
-3,387
-10% -$646K 0.04% 294
2015
Q3
$5.56M Buy
35,556
+4,562
+15% +$714K 0.04% 310
2015
Q2
$5.6M Sell
30,994
-960
-3% -$174K 0.03% 327
2015
Q1
$5.54M Sell
31,954
-2,941
-8% -$510K 0.03% 346
2014
Q4
$6.46M Buy
34,895
+685
+2% +$127K 0.04% 318
2014
Q3
$5.67M Buy
34,210
+25,210
+280% +$4.18M 0.04% 346
2014
Q2
$1.41M Sell
9,000
-836
-8% -$131K 0.06% 226
2014
Q1
$1.5M Sell
9,836
-2,108
-18% -$321K 0.06% 206
2013
Q4
$1.59M Sell
11,944
-1,568
-12% -$208K 0.07% 200
2013
Q3
$1.57M Sell
13,512
-3,618
-21% -$420K 0.07% 182
2013
Q2
$1.58M Buy
+17,130
New +$1.58M 0.08% 184